Dialysis Associated Hepatitis

  • Jean Crosnier
  • FranÇoise Degos
  • Paul Jungers

Abstract

Viral hepatitis, especially type B hepatitis, is a major problem in dialysis units throughout the world. Due to the deficient immune status of uremic subjects, which renders them unable to eliminate the virus, infected patients acting as virus reservoirs transmit the infection to other patients, to dialysis unit staff, to other categories of hospital personnel, and to their own families.

Keywords

Dialysis Patient Dialysis Unit Geometric Mean Titer Healthy Staff Pasteur Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jones PO, Goldsmith HJ, Wright FK, Roberts C, Watson DC: Viral hepatitis: a staff hazard in dialysis units. Lancet 1: 835, 1967PubMedCrossRefGoogle Scholar
  2. 2.
    Eastwood JB, Curtis JR, Wing AJ, de Wardener HE: Hepatitis in a maintenance hemodialysis unit Ann Intern Med 69:59, 1966Google Scholar
  3. 3.
    Ringertz O, Nystrôm B: Viral hepatitis in connection with hemodialysis and kidney transplantation. Scand J Urol Nephrol 1:192, 1967CrossRefGoogle Scholar
  4. 4.
    Ringertz O, Nystrôm B: Hepatitis B in a haemodialysis unitLancet 2: 745 1969PubMedCrossRefGoogle Scholar
  5. 5.
    Jacobs C, Legrain M: A propos d’une épidémie d’hépatite dans un centre d’hémodialyse chronique (Apropos of an epidemic of hepatitis in a chronic dialysis center.) J Urol Nephrol 74: 333, 1968Google Scholar
  6. 6.
    Leski M, Grivaux C, Couroucé-Pauty AM: L’antigène Australie dans un unité d’hémodialyse périodique et de transplantation. (Austrialia antigen in a periodic hemodialysis and renal transplantation unit) Presse Méd 79: 391, 1971PubMedGoogle Scholar
  7. 7.
    Forrest JN Jr, Dismukes WE: Dialysis-associated hepatitis in 108 U.S. hemodialysis unitsClin Res 16: 383, 1968Google Scholar
  8. 8.
    Friedman EA, Thomson GE: Hepatitis complicating chronic haemodialysis. Lancet 2: 675, 1966PubMedCrossRefGoogle Scholar
  9. 9.
    London WT, DiFiglia M, Sutnick AI, Blumberg BS: An epidemic of hepatitis in a chronic hemodialysis unit. Australia antigen and differences in host response. N Engl J Med 281: 571, 1969PubMedCrossRefGoogle Scholar
  10. 10.
    Huggins CE, Blumberg BS, Giger K, Grady GF: Hepatitis in hemodialysis units. N Engl J Med 263: 657, 1970Google Scholar
  11. 11.
    Bone JM, Tonkin RW, Davison AM, Marmion BP, Robson JS: Outbreak of dialysis-associated hepatitis in Edinburgh, 1969–1970. Proc Eur Dial Transplant Assoc 8: 189, 1971Google Scholar
  12. 12.
    Drukker W, Haagsma-Schouten WAG, Albert C, Baarda B: Report on regular dialysis treatment in Europe.Proc Eur Dial Transplant Assoc 7: 3, 1970Google Scholar
  13. 13.
    Parsons FM, Brunner FP, Gurland HJ, Hàrlen H: Combined report on regular dialysis and transplantation in Europe, I, 1970. Proc Eur Dial Transplant Assoc 8: 3, 1971Google Scholar
  14. 14.
    Gurland HJ, Brunner FP, Dehn H, Hàrlen H, Parsons FM, Schàrer K: Combined report on regular dialysis and transplantation in Europe, III, 1972. Proc Eur Dial Transplant Assoc 8: 17, 1973Google Scholar
  15. 15.
    Garibaldi RA, Forrest JN, Bryan JA, Hanson BF, Dismukes WWE: Hemodialysis-associated hepatitis. JAMA 255: 384, 1973CrossRefGoogle Scholar
  16. 16.
    Blumberg BS, Sutnick AI, London WT: Hepatitis and leukemia: their relation to Australia antigen. Bull NY Acad Med 44: 1566, 1968Google Scholar
  17. 17.
    Prince AM: An antigen detected in the blood during the incubation of serum hepatitis. Proc Natl Acad Sci USA 60: 814, 1968PubMedCrossRefGoogle Scholar
  18. 18.
    Parsons FM, Brunner FP, Burck HC, Gräser W, Gurland HJ, Härlen H, Schärer K, Spies GW: Statistical report. Proc Eur Dial Transplant Assoc 11: 53, 1974Google Scholar
  19. 19.
    Szmuness W, Prince AM, Grady GF, Mann MK, Levine RN, Friedman EA, Jacobs MJ, Josephson A, Ribot S, Shapiro FL, Stenzel KH, Suki WN, Vyas G: Hepatitis B infection: a pointprevalence study in 15 US hemodialysis centers. JAMA 227: 901, 1974PubMedCrossRefGoogle Scholar
  20. 20.
    Brynger H, Brunner FP, Chantier C, Donckerwolcke RA, Jacobs C, Kramer P, Sciwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe, X, 1979. Proc Eur Dial Transplant Assoc 17: 2, 1980PubMedGoogle Scholar
  21. 21.
    Jacobs C, Broyer M, Brunner FP, Brynger H, Donckerwolcke RA, Kramer P, Sciwood NJ, Wing AJ, Blake AH: Combined report on regular dialysis and transplantation in Europe, XI, 1980. Proc Eur Dial Transplant Assoc 18: 2, 1981Google Scholar
  22. 22.
    Broyer M, Brunner FP, Brynger H, Donckerwolcke RA, Jacobs C, Kramer P, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe XII, 1981. Proc Eur Dial Transplant Assoc 19: 4, 1982Google Scholar
  23. 23.
    Wing AJ, Broyer M, Brunner FP, Brynger H, Challah S, Donckerwolcke RA, Gretz N, Jacobs C, Kramer P, Selwood NH: Combined report on regular dialysis and transplantation in Europe XIII, 1982. Proc Eur Dial Transplant Assoc 20: 5, 1983Google Scholar
  24. 24.
    Kramer P, Broyer M, Brunner FP, Brynger H, Challah S, Oulès R, Rizzoni G, Selwood NH, Wing AJ, Balas EA: Combined report on regular dialysis and transplantation in Europe XIV, 1983. Proc Eur Dial Transplant Assoc Eur Ren Assoc 2: 5, 1984Google Scholar
  25. 25.
    Brunner FP, Broyer M, Brynger H, Challah S, Fassbinder W, Oulès R, Rizzoni G, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe, XV, 1984. Proc Eur Dial Transplant Assoc Eur Ren Assoc 22: 5, 1985Google Scholar
  26. 26.
    Oulès R, Fassbinder W, Broyer M, Brunner FP, Brynger H, Challah S, Guillou PJ, Rizzoni G, Selwood NH, Wing AJ: Combined report on regular dialysis and transplantation in Europe, XVI, 1985Google Scholar
  27. 27.
    Bradley DW, Maynard JE, Hindman SH, Hornbech CL, Fields HA, McCaustland KA, Cook EH: Serodiagnosis of viral hepatitis A by radioimmunoassay. J Clin Microbiol 5: 521, 1977PubMedGoogle Scholar
  28. 28.
    Feinstone SM, Purcell RH: New methods for the serodiagnosis of hepatitis A. Gastroenterology 78: 1092, 1980PubMedGoogle Scholar
  29. 29.
    Szmuness W, Dienstag JL, Purcell RH, Prince AM, Stevens CE, Levine RW: Hepatitis type A and hemodialysis. Ann Intern Med 87: 8, 1977PubMedGoogle Scholar
  30. 30.
    Mathiesen LR, Hardt F, Dietrichson O, Purcell RH, Wong D, Skinhoj P, Nielsen JO, Zoffman H, Iversen K: The Copenhagen hepatitis acuta programme. The role of acute hepatitis A, B and non-A, non-B in the development of chronic active liver disease. Scand J Gastroenterol 15: 49, 1980PubMedCrossRefGoogle Scholar
  31. 31.
    Alter HJ, Holland PV, Purcell RH: The emerging pattern of post-transfusion hepatitis. Am J Med Sci 270: 329, 1975PubMedCrossRefGoogle Scholar
  32. 32.
    Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV: Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 292: 767, 1975PubMedCrossRefGoogle Scholar
  33. 33.
    Alter HJ, Purcell RH, Holland PV, Feinstone SM, Morrow AG, Moritsugu Y: Clinical and serological analysis of tranfusion-associated hepatitis. Lancet 2: 838, 1975PubMedCrossRefGoogle Scholar
  34. 34.
    Hoofnagle JA, Gerety RJ, Tabor E, Feinstone SM, Barker LF, Purcell RH: Transmission of non-A, non-B hepatitis. Ann Intern Med 87: 14, 1977PubMedGoogle Scholar
  35. 35.
    Aach RD, Szmuness W, Mosley JW, Hollinger FB, Kahn R, Stevens CE, Edwards VM, Weich J: Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. N Engl J Med 304: 899, 1981CrossRefGoogle Scholar
  36. 36.
    Galbraith RM, Portman B, Eddieston ALWF, Williams R, Gower PE: Chronic liver disease developing after outbreak of HBsAg-negative hepatitis in haemodialysis unit. Lancet 2: 886, 1975PubMedCrossRefGoogle Scholar
  37. 37.
    Avram MM, Feinfeld DA, Gan AC: Non-A, non-B hepatitis: a new syndrome in uraemic patients. Proc Eur Dial Transplant Assoc 16: 141, 1979PubMedGoogle Scholar
  38. 38.
    Galbraith RM, Dienstag JL, Purcell RH, Gower PH, Zuckerman AJ, Williams R: Non-A, non-B hepatitis associated with chronic liver disease in a haemodialysis unit. Lancet 1: 951, 1979PubMedCrossRefGoogle Scholar
  39. 39.
    Simon N, Mery JP, Trepo C, Vitvitski L, Courouce AM: A non-A, non-B hepatitis epidemic in an HB antigen-free hemodialysis unit. Demonstration of serological markers of non-A, non-B virus. Proc Eur Dial Transplant Assoc 17:173, 1980PubMedGoogle Scholar
  40. 40.
    Berman M, Alter HJ, Ishak KG, Purcell RH, Jones EA: The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med 91:1, 1979PubMedGoogle Scholar
  41. 41.
    Knodell RG, Conrak ME, Ishak KG: Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Gastroenterology 72: 902, 1977PubMedGoogle Scholar
  42. 42.
    Rakela J, Redeker AG: Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology 77:1200, 1979PubMedGoogle Scholar
  43. 43.
    Nielsen V, Clausen E, Ranek L: Liver impairment during chronic hemodialysis and after renal transplantationActa Med Scand 197: 229, 1975PubMedCrossRefGoogle Scholar
  44. 44.
    Reed W, Lucas ZJ, Kempson R, Cohn R: Renal transplantation in patients with Australian antigenemiaTransplant Proc 3: 342, 1971Google Scholar
  45. 45.
    Thomas DR, Bogie W, Blainey JD, Robinson BHB, Dawson-Edwards P, Barnes AD: Hepatitis in a renal transplant unit. Br J Surg 59: 310, 1972PubMedGoogle Scholar
  46. 46.
    Aronoff A, Gault MH, Haung SH: Hepatitis with Australia antigenemia following renal transplantation. Canad Med Assoc J 108: 43, 1973PubMedGoogle Scholar
  47. 47.
    Ware AJ, Luby JP, Hollinger B, Eigenbrodt EH, Cuthbert JA, Atkins CR, Shorey J, Hull AR, Combes B: Etiology of liver disease in renal transplant patients. Ann Intern Med 91: 364, 1979PubMedGoogle Scholar
  48. 48.
    Degos F, Degott C, Bedrossian J, Camilieri JP, Barbanel C, Duboust A, Rueff B, Benhamou JP, Kreis H: Is renal transplantation involved in post-transplantation liver disease? A prospective study. Transplantation 29: 100, 1980PubMedCrossRefGoogle Scholar
  49. 49.
    La Quaglia NP, Tolkoff-Rubin NE, Dienstag JL, Cosimi AB, Herrin JT, Kelly M, Rubin RH: Impact of hepatitis on renal transplantation. Transplantation 32: 504, 1981CrossRefGoogle Scholar
  50. 50.
    Parfrey PS, Forbes RDC, Hutchinson TA, Kenick S, Farge E, Dauphinee WD, Seely JF, Guttman RD: The impact of renal transplantation on the course of hepatitis B liver disease. Transplantation 39: 610, 1985PubMedCrossRefGoogle Scholar
  51. 51.
    Weir MR, Kirkman RL, Strom TB, Tilney NL: Liver disease in recipients of long-functioning renal allografts. Kidney Int 28: 839, 1985PubMedCrossRefGoogle Scholar
  52. 52.
    Dusheiko G, Song E, Bowyer S, Whitcutt M, Maier G, Meyers A, Kew MC: Natural history of hepatitis B virus infection in renal transplant recipients. A fifteen-year follow-up. Hepatology 3: 330, 1983PubMedCrossRefGoogle Scholar
  53. 53.
    Degos F, Debure A, Kreis H: Hepatitis in renal transplant recipients. Transplantation Rev 1: 159, 1987CrossRefGoogle Scholar
  54. 54.
    Degast GC, Houwen B, Van der Hem GK, The JH: T lymphocyte number and function and the course of hepatitis B in hemodialysis patients. Infect Immun 14: 1138, 1976Google Scholar
  55. 55.
    Descamps B, Jungers P, Naret C, Zingraff J, Bach JF: HLA 1 B 8 phenotype association and HBs antigenemia evolution in 440 hemodialyzed patients. Digestion 15: 171, 1977CrossRefGoogle Scholar
  56. 56.
    Robinson WS: Hepatitis B Dane particle DNA structure and the mechanism of the endogenous DNA polymerase reaction. In: Viral Hepatitis edited by Vyas GN, Cohen JN, Schmid R, Philadelphia, Franklin Institute Press, 1978, p 139Google Scholar
  57. 57.
    Bréchot C, Hadchouel M, Scotto J, Degos F, Charnay P, Trépo C, Tiollais P, Berthelot P: Detection of hepatitis B virus DNA in liver and serum: a direct appraisal of the chronic carrier state. Lancet 2: 765, 1981PubMedCrossRefGoogle Scholar
  58. 58.
    Bonino F, Hoyer B, Ford E, Shih JW, Purcell RH, Gerin JL: Hepatitis B virus DNA in the sera of HBs carriers. Hepatology 1: 386, 1981PubMedCrossRefGoogle Scholar
  59. 59.
    Hoofnagle JH, Seeff LB, Bales ZB, Gerety RJ, Tabor E: Serologic responses in hepatitis B. In:Viral Hepatitis edited by Vyas GN, Cohen SN, Schmid R, Philadelphia, Franklin Institute Press, 1978, p 219Google Scholar
  60. 60.
    Overby LR, Ling CM, Decker RH, Mushahwar IK, Chau K: Serodiagnostic profiles of viral hepatitis. In: Viral Hepatitis edited by Szmuness W, Alter HJ, Maynard JE, Philadelphia, Franklin Institute Press, 1981, p 169Google Scholar
  61. 61.
    Nordenfeit E, Lindholm T, Lofgren B, Moestrup T, Reinicke V: Different categories of chronic HBsAg carriers; a long-term follow up. In: Viral Hepatitis edited by Szmuness W, Alter HJ, Maynard JE, Philadelphia, Franklin Institute Press, 1981,p 237Google Scholar
  62. 62.
    Hoofnagle JH, Alter HJ: Chronic viral hepatitis. In: Viral Hepatitis and Liver Disease edited by Vyas GN, Dienstag JL, Hoofnagle JH, Orlando, Grune and Stratton, 1984, p 97Google Scholar
  63. 63.
    Coughlin GP, Van Deth AG, Disney APS, Hay J, Wangel AG: Liver disease and the e antigen in HBsAg carriers with chronic renal failure. Gut 21: 118, 1980PubMedCrossRefGoogle Scholar
  64. 64.
    Degott C, Degos F, Jungers P, Naret C, Couroucé AM, Potet F, Crosnier J: Relationship between liver histopathological changes and HBsAg in 111 patients treated by long-term hemodialysis. Liver 3: 377, 1983PubMedGoogle Scholar
  65. 65.
    Lebrec D, Degott C, Rueff B, Benhamou JP: Transvenous (transjugular) liver biopsy: an experience based on 100 biopsies. Am J Dig Dis 23: 302, 1978PubMedCrossRefGoogle Scholar
  66. 66.
    Scheuer PJ: Liver Biopsy Interpretation 3rd edition, London, Baillière Tindall, 1980Google Scholar
  67. 67.
    Parfrey PS, Forbes RDC, Hutchinson TA, Beaudoin JG, Dauphinee WD, Guttmann RD: The prevalence and progression of liver disease in renal transplant recipients: a histological study. Transplant Proc 16: 1103, 1984Google Scholar
  68. 68.
    Rizetto M: The delta agent. Hepatology 3: 729, 1983CrossRefGoogle Scholar
  69. 69.
    Kharsa G, Degott C, Degos F, Carnot F, Potet F, Kreis H: Fulminant hepatitis in renal transplant recipients: role of delta agentTransplantation 44: 221, 1987PubMedCrossRefGoogle Scholar
  70. 70.
    Sopko J, Anuras S: Liver disease in renal transplant recipientsAm J Med 64: 139, 1978PubMedCrossRefGoogle Scholar
  71. 71.
    Ware AJ, Luby JP, Eigenbrodt EM, Long DL, Hull AR: Spectrum of liver disease in renal transplant recipientsGastroenterology 68: 755, 1975PubMedGoogle Scholar
  72. 72.
    Cheeseman SH, Henle W, Rubin RH, Tolkoff-Rubin NE, Cosimi E, Cantell K, Winkle S, Herrin JT, Black PH, Russell PS, Hirsch MS: Epstein-Barr virus infection in renal transplant recipients; effect of antithymocyte globulin and interferon. Ann Intern Med 93: 39, 1980PubMedGoogle Scholar
  73. 73.
    Elliott WC, Houghton DC, Bryant RE, Wicklund R, Bany JM, Bennett WM: Herpes simplex type 1 hepatitis in renal transplantationArch Intern Med 140: 1656, 1968CrossRefGoogle Scholar
  74. 74.
    Holdsworth SR, Atkins RC, Scott DF, Hayes K: Systemic herpes simplex infection with fulminant hepatitis post-transplantationAust NZ J Med 6: 588, 1976CrossRefGoogle Scholar
  75. 75.
    Montgomerie JZ, Becroft DMO, Croxson MC, Doak PB, North JDK: Herpes simplex virus infection after renal transplantationLancet 2: 867, 1969PubMedCrossRefGoogle Scholar
  76. 76.
    Trépo C, Vitvitski L, Hantz O, Pichoud C, Blancy B, Chevallier P, Trépo D, Babin S, Sepetjan M: Characterization and detection of a virus related to HBV in NANB hepatitis. In: Viral Hepatitis edited by Szmuness W, Alter HJ, Maynard JE, Philadelphia, Franklin Institute Press, 1981, p 339Google Scholar
  77. 77.
    Trépo C, Degos F, Vitvitski L, Calson R, Chossegros P, Pichard C, Hantz D, Chevallier P, Chevré JC, Simon N, Peyrol S, Grimaud JA, Feldman G, Sepetjan M, Wands J: Evidence for a transmissible Non A non B agent inextricably linked with hepatitis B virus. In: Viral Hepatitis and Liver Disease, edited by Vyas GN, Dienstag JL, Hoofnagle JH, Orlando, Grune and Stratton 1984, p 355Google Scholar
  78. 78.
    Alter HJ, Hoofnagle JH: Non A non B observations on the first decade. In: Viral Hepatitis and Liver Disease edited by Vyas GN, Dienstag JL, Hoofnagle JH, Orlando, Grune and Stratton 1984, p 345Google Scholar
  79. 79.
    Schafritz DA, Lieberman HM, Isselbacher KJ, Wands JR: Monoclonal radioimmunoassays for hepatitis B surface antigen. Demonstration of hepatitis B virus DNA or related sequences in serum and viral epitopes in immune complexes. Proc Natl Acad Sci USA 79: 5675, 1982CrossRefGoogle Scholar
  80. 80.
    Fujita YK, Kamata K, Kameda H, Isselbacher KJ, Wands JR: Detection of hepatitis B virus infection in hepatitis B surface antigen negative hemodialysis patients by monoclonal radioimmunoassays. Gastroenterology 91: 1457, 1986Google Scholar
  81. 81.
    Wands J, Fujita YK, Isselbacher K, Degott C, Schellekens H, Dazza MC, Thiers V, Tiollais P, Brechot C: Identification and transmission of hepatitis-related variants. Proc Natl Acad Sci USA 83: 6608, 1986PubMedCrossRefGoogle Scholar
  82. 82.
    Bréchot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco DBismuth H, Trépo C, Benhamou JP, Wands J, Isselbacher K, Tiollais P, Berthelot P:Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 312: 270, 1985PubMedCrossRefGoogle Scholar
  83. 83.
    Degos F, Lugassy C, Degott C, Debure A, Carnot F, Thiers V, Tiollais P, Kreis H, Bréchot C: HBV and HBV related infection in renal transplant recipients. A prospective study of 90 patients. Gastroenterology 94: 151, 1988PubMedGoogle Scholar
  84. 84.
    Figus A, Blum HE, Vyas GN, Virgilis S, Cao A, Lippi M, Lai EBalestrieri A: Hepatitis B nucleotide sequences in non A non B or hepatitis B related chronic liver diseaseHepatology 4: 364, 1984PubMedCrossRefGoogle Scholar
  85. 85.
    Harrison TJ, Anderson MG, Murray Lyon IM, Zuckerman AJ: Hepatitis B virus DNA in the hepatocytes: a series of 160 biopsies. J Hepatol 1:10, 1986Google Scholar
  86. 86.
    Ware AJ, Gorder NL, Gurian LE, Douglas C, Shorey JW, Parker T: Value of screening for markers of hepatitis in dialysis units. Hepatology 3: 513, 1983PubMedCrossRefGoogle Scholar
  87. 87.
    Hillis WD, Hillis A, Walter WG: Hepatitis B surface antigenemia in renal transplant recipients. Increased mortality risk. JAMA 243: 329, 1979CrossRefGoogle Scholar
  88. 88.
    Kirkman RL, Strom TB, Weir MR, Tilney NL: Late mortality and morbidity in recipients of long-term renal allografts. Transplantation 34: 347, 1982PubMedCrossRefGoogle Scholar
  89. 89.
    Weissberg JI, Andres LL, Smith CI, Weick S, Nichols JE, Garcia G, Robinson WS, Merigan TC, Gregory PB: Survival in chronic hepatitis B. An analysis of 379 patients. Ann Intern Med 101: 613, 1984PubMedGoogle Scholar
  90. 90.
    London WT, Drew JS, Blumberg BS, Grossmann PA, Lyons PJ: Association of graft survival with host response to hepatitis B infection in patients with kidney transplants. N Engl J Med 296: 241, 1969CrossRefGoogle Scholar
  91. 91.
    Pirson Y, Alexandre GPJ, Van Ypersele de Strihou C: Long-term effect of HBs antigenemia on patient survival after renal transplantation. N Engl J Med 296: 194, 1977PubMedCrossRefGoogle Scholar
  92. 92.
    Villa E, Rubbiana L, Barchi T, Ferretti I, Grisendi A, de Palma M, Bellentani S, Manenti F: Susceptibility of chronic symptomless HBsAg carriers to ethanol induced hepatic damage. Lancet 2: 1243, 1982PubMedCrossRefGoogle Scholar
  93. 93.
    Hoofnagle JH, Davis GL, Pappas SC, Hanson RG, Peters M, Arigan MI, Waggoner JG, Jones A, Seeff LB: A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. Ann Intern Med 104: 12, 1986PubMedGoogle Scholar
  94. 94.
    Lam KC, Lai CL, Trépo C, Wu PC: Deleterious effect of prednisolone in HBsAg positive chronic active hepatitis. N Engl J Med 304: 380, 1981PubMedCrossRefGoogle Scholar
  95. 95.
    Sagnelli E, Piccinino F, Manzillo G, Felaco FM, Filippini P, Maio G, Pasquale G, Izzo C: Effect of immunosuppressive therapy on HBsAg positive chronic active hepatitis in relation to presence or absence of HBeAg and anti-HBe. Hepatology 5: 690, 1983Google Scholar
  96. 96.
    Bréchot C, Nalpas B, Couroucé AM, Duhamel G, Callard P, Carnot F, Tiollais P, Berthelot P: Evidence that hepatitis B has a role in liver cell carcinoma in alcoholic liver disease. N Engl J Med 306; 1384, 1982PubMedCrossRefGoogle Scholar
  97. 97.
    Kew MC: The hepatitis B virus and hepatocellular carcinoma. Semin Liver Disease 1: 59, 1981CrossRefGoogle Scholar
  98. 98.
    Shafritz DA, Shouval JD, Sherman HI, Hadziyannis S J, Kew MC: Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. N Engl J Med 305: 1067, 1981PubMedCrossRefGoogle Scholar
  99. 99.
    Arbus GS, Hung RH: Hepatocarcinoma and myocardial fibrosis in an 8–3/4 year old renal transplant recipient. Canad Med Assoc J 107: 431, 1972PubMedGoogle Scholar
  100. 100.
    Schroeter GPJ, Weill R, Penn I, Speers WC, Waddell WR: Hepatocellular carcinoma assoicated with hepatitis B infection after kidney transplantation. Lancet 2: 381, 1982CrossRefGoogle Scholar
  101. 101.
    Reinicke V, Dybkjaer E, Poulsen H, Banke O, Lylloff K, Nordenfeit E: A study of Australia-antigen positive blood donors and their recipients with special reference to liver histology. N Engl J Med 286: 867, 1972PubMedCrossRefGoogle Scholar
  102. 102.
    Couroucé-Pauty AM, Soulier JP: Further data on HBs antigen subtypes. Geographical distribution. Vox Sang 27: 533, 1974PubMedCrossRefGoogle Scholar
  103. 103.
    Soulier JP, Jüngers P, Zingraff J: Virus B hepatitis in hemodialysis centers. Adv Nephrol 6: 383, 1976Google Scholar
  104. 104.
    Polakoff S, Cossart YE, Tillett HE: Hepatitis in dialysis units in the United Kingdom. Br Med J 3: 94, 1972PubMedCrossRefGoogle Scholar
  105. 105.
    Turner GC, Bruce-White GB: SH antigen in haemodialysis-associated hepatitis. Lancet 2: 121, 1969PubMedGoogle Scholar
  106. 106.
    Pattison CP, Maynard JE, Berquist KR, Webster HM: Serological and epidemiological studies of hepatitis B in haemodialysis units. Lancet 2: 172, 1973PubMedCrossRefGoogle Scholar
  107. 107.
    Dankert J, Uitentuis J, Houwen B, Tegzess AM, van der Hem GK: Hepatitis B surface antigen in environmental samples from hemodialysis units. J Infect Dis 134: 112, 1976CrossRefGoogle Scholar
  108. 108.
    Salo RJ, Salo AA, Fahlberg WJ, Ellzey JP: Hepatitis B surface antigen (HBsAg) in peritoneal fluid of HBsAg carriers undergoing peritoneal dialysis. J Med Virol 6: 29, 1980PubMedCrossRefGoogle Scholar
  109. 109.
    Heathcote H, Cameron CH, Dane DS: Hepatitis B antigen in saliva and semen. Lancet 1: 71, 1974PubMedCrossRefGoogle Scholar
  110. 110.
    Public Health Laboratory Service: Infection risks of haemodialysis: some preventive aspects. Br Med J 3: 454, 1968CrossRefGoogle Scholar
  111. 111.
    Department of Health and Social Security: Report of the Advisory Group on Hepatitis and the Treatment of Chronic Renal Failure 1970–1972. London DHSS, 1972Google Scholar
  112. 112.
    Public Health Laboratory Service Survey: Decrease in the incidence of hepatitis in dialysis units associated with prevention programme. Br Med J 4: 751, 1974CrossRefGoogle Scholar
  113. 113.
    Public Health Laboratory Service: Hepatitis in retreat from dialysis units in United Kingdom in 1973. Br Med J 1: 1579, 1976CrossRefGoogle Scholar
  114. 114.
    Krugman S, Giles JP, Hammond J: Viral hepatitis, type B (MS-2 strain): prevention with specific hepatitis B immune serum globulin. JAMA 218:1665, 1971PubMedCrossRefGoogle Scholar
  115. 115.
    Szmuness W, Prince AM, Goodman M, Ehrlich C, Pick R, Ansari M: Hepatitis B immune serum globulin in prevention of nonparenterally transmitted hepatitis B. N Engl J Med 290: 701, 1974PubMedCrossRefGoogle Scholar
  116. 116.
    Hoofnagle JH, Seeff LB, Bales BZ, Wright EC, Zimmerman HJ, The Veterans Administration Cooperative Study Group: Passive-active immunity from hepatitis B immune globulin. Ann Intern Med 91: 813, 1979PubMedGoogle Scholar
  117. 117.
    Desmyter J, Bradburne AF, Vermylen C, Daneeis R, Boelaert J: Hepatitis B immunoglobulin in prevention of HBs antigenaemia in haemodialysis patients. Lancet 2: 377, 1975CrossRefGoogle Scholar
  118. 118.
    Surgenor DMacN, Chalmers TC, Conrad ME, Friedwald WT, Grady GF, Hamilton M, Mosley JW, Prince AM, Stengle JM: Clinical trials of hepatitis B immune globulin. N Engl J Med 293:1060, 1975PubMedCrossRefGoogle Scholar
  119. 119.
    Kleinknecht D, Couroucé AM, Delons S, Naret C, Adhémar SP, Ciancioni C, Fermanian J: Prevention of hepatitis B in hemodialysis patients using hepatitis B immunoglobulin. Clin Nephrol 8: 373, 1977PubMedGoogle Scholar
  120. 120.
    Prince AM, Szmuness W, Mann MK, Vyas GN, Grady GF, Shapiro FL, Suki WN, Friedman EA, Avram MM, Stenkel KH: Hepatitis B immune globulin: Final report of a controlled multicentre trial of efficacy in prevention of dialysis-associated hepatitis. J Infect Dis 137: 131, 1978PubMedCrossRefGoogle Scholar
  121. 121.
    Iwarson S, Ahlmén J, Eriksson E, Hermodsson S, Kjellman H, Ljunggren C, Sciander D: Hepatitis B immune globulin in prevention of hepatitis B among hospital staff members. J Infect Dis 135: 473, 1977PubMedCrossRefGoogle Scholar
  122. 122.
    Couroucé-Pauty AM, Delons S, Soulier JP: Attempt to prevent hepatitis by using specific anti-HBs immunoglobulin. Am J Med Sci 270: 375, 1975PubMedCrossRefGoogle Scholar
  123. 123.
    Seeff LB, Wright EC, Zimmerman HJ, Alter HJ, Dietz AA, Felsher BF, Finkelstein JD, Garcia-Pont P, Gerin JL, Greenlee HB, Hamilton J, Holland PV, Kaplan PM, Kiernan T, Koff RS, Leevy CM, McAuliffe VJ, Nath N, Purcell RH, Schiff ER, Schwartz CC, Tamburro CH, Vlahcevic Z, Zemel R, Zimmon DS: Type B hepatitis after needlestick exposure: Prevention with hepatitis B immunoglobulin. Ann Intern Med 88: 285, 1978PubMedGoogle Scholar
  124. 124.
    Grady GF, Lee VA, Prince AM, Gitnick GL, Fawaz KA, Vyas GN, Levitt MD, Senior JR, Galambos JT, Bynum TE, Singleton JW, Clowdus BF, Akdamar K, Aach RD, Winkleman EI, Schiff GM, Hersch T: Hepatitis B immune globulin for accidental exposure among medical personnel: final report of a multicentre controlled trial. J Infect Dis 138: 625, 1978PubMedCrossRefGoogle Scholar
  125. 125.
    Courouce AM, Bouchardeau F, Le Marrec N, Boulard G, Soulier JP: The use of hepatitis B vaccine as booster for donors immune to HBV for the production of hepatitis B immunoblobulin (HBIG). In: Second WHO HABS Symposium on Viral Hepatitis Basel, S Karger, 1983, p 333Google Scholar
  126. 126.
    Krugman S, Giles JP, Hammond J: Viral hepatitis, type B (MS-2 strain): studies on active immunization. JAMA 217:41, 1971PubMedCrossRefGoogle Scholar
  127. 127.
    Jungers P, Delagneau JF, Prunet P, Crosnier J: Vaccination against hepatitis B in hemodialysis centers. Adv Nephrol 11: 303, 1982Google Scholar
  128. 128.
    Stevens CE, Taylor PE, Tong MJ, Toy PT, Vyas GN: Hepatitis B vaccine: an overview. In:Viral Hepatitis and Liver Disease edited by Vyas GN, Dienstag JL, Hoofnagle JH, Orlando, Grune and Stratton, 1984, p 275Google Scholar
  129. 129.
    Jacobson IM, Dienstag JI: Viral hepatitis vaccines. Annu Rev Med 36: 241, 1985PubMedCrossRefGoogle Scholar
  130. 130.
    Hilleman MR, Buynak EB, Roehm RR, Tytell AA, Bertland AV, Lampson GP: Purified and inactivated human hepatitis B vaccine: Progress report. Am J Med Sci 270: 401, 1975PubMedCrossRefGoogle Scholar
  131. 131.
    Maupas P, Goudeau A, Coursaget P, Drucker J: Immunization against hepatitis B in man. Lancet 1: 1367, 1976PubMedCrossRefGoogle Scholar
  132. 132.
    Adamowicz P, Gerfaux G, Platel A, Muller L, Vacher B, Mazert MC, Prunet P: Large scale production of an hepatitis B vaccine. In: Hepatitis B Vaccine edited by Maupas P, Guesry P, Amsterdam, Elsevier-North Holland, 1981, p 37Google Scholar
  133. 133.
    Brummelhuis HGJ, Wilson-De Stüler LA, Raap AK: Preparation of hepatitis B vaccine by heat inactivation. In: Hepatitis B Vaccine edited by Maupas P, Guesry P, Amsterdam, Elsevier-North Holland, 1981, p 51Google Scholar
  134. 134.
    Purcell RH, Gerin JL: Hepatitis B subunit vaccine: a preliminary report on safety and efficacy tests in chimpanzees. Am J Med Sci 270: 395, 1975PubMedCrossRefGoogle Scholar
  135. 135.
    Hepatitis B vaccine: evidence confirming lack of AIDS transmission. MMWR 33: 685, 1984Google Scholar
  136. 136.
    Adamowicz P, Chabanier G, Hyafil F, Lucas G, Prunet P, Reculard P, Vinas R: Elimination of serum proteins and potential virus contaminants during hepatitis B vaccine preparation. Vaccine 2: 209, 1984PubMedCrossRefGoogle Scholar
  137. 137.
    Szmuness W: Large-scale efficacy trials of hepatitis B vaccines in the USA: baseline data and protocols. J Med Virol 4: 327, 1979PubMedCrossRefGoogle Scholar
  138. 138.
    Szmuness W, Stevens CE, Harley EJ, Zang EA, Olesko WR, William DC, Sadovsky R, Morrison JM, Kellnar A: Hepatitis B vaccine. Demonstration of efficacy in controlled clinical trial in a high-risk population in the United States. N Engl J Med 303: 833, 1980PubMedCrossRefGoogle Scholar
  139. 139.
    Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A: A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report. Hepatology 1: 377, 1981PubMedCrossRefGoogle Scholar
  140. 140.
    Crosnier J, Jungers P, Courouce AM, Laplanche A, Benhamou E, Degos F, Lacour B, Prunet P, Cerisier Y, Guersy P: Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units. I. Medical staff. Lancet 1: 455, 1981PubMedCrossRefGoogle Scholar
  141. 141.
    Laplanche A, Courouce AM, Benhamou E, Jungers P, Crosnier J: Response to hepatitis B vaccine. Lancet 1: 222, 1982PubMedCrossRefGoogle Scholar
  142. 142.
    Szmuness W, Stevens CE, Harley EJ, Zang EA, Alter JH, Taylor PE, De Vera A, Chen GTS, Kellner A: Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection. N Engl Med 307: 1481, 1982CrossRefGoogle Scholar
  143. 143.
    Desmyter J, Colaert J, De Groote G, Reynders M, Reerink-Brongers EE, Lehe PN, Dees PJ, Reesink HW: Efficacy of heat-inactivated hepatitis B vaccine in haemodialysis patients and staff. Double-blind placebo-controlled trial. Lancet 2: 1323, 1983PubMedCrossRefGoogle Scholar
  144. 144.
    Dienstag JI, Werner BG, Polk BH, Snydman DR, Craven DE, Platt R, Crumpacker CS, Quellet-Hellstrom R, Grady GF: Hepatitis B vaccine in health care personnel: Safety, immunogenicity and indicators of efficacy. Ann Intern Med 101: 34, 1984PubMedGoogle Scholar
  145. 145.
    Goudeau A, Dubois F, Barin F, Dubois MC, Coursaget P: Hepatitis B vaccines: clinical trials in high-risk setting in France (September 1975 - September 1982). In: Second WHO HABS Symposium on Viral Hepatitis Basel, Karger 1983,p 267Google Scholar
  146. 146.
    Strickler AC, Kibsey PC, Vellend H: Seroconversion rates with hepatitis B vaccine. Ann Intern Med 101: 564, 1984PubMedGoogle Scholar
  147. 147.
    Schaaf DM, Lender M, Suedeker P, Graham LA: Hepatitis B vaccine in a hospital. Ann Intern Med 101: 720, 1984Google Scholar
  148. 148.
    Ukena T, Esber H, Bessette R, Parks T, Crockers B, Shaw FE: Site of injection and response to hepatitis B vaccine. N Engl J Med 313: 579, 1985PubMedGoogle Scholar
  149. 149.
    Francis DP, Hadler SC, Thompson SE, Maynard JE, Ostrow DG, Altman N, Braff EH, O’Malley PM, Hawkins JD, Judson FN, Penley K, Nylund T, Christie G, Meyers F, Moore JN, Gardner A, Doto IL, Miller JH, Reynolds GH, Murphy BL, Schable CA, Clark BT, Curran JW, Redeker AG: The prevention of hepatitis B with vaccine: report of the Centers for Disease Control multi-center efficacy trial among homosexual men. Ann Intern Med 97: 362, 1982PubMedGoogle Scholar
  150. 150.
    Centers for Disease Control: Suboptimal response to hepatitis B vaccine given by injection into the buttock MMWR 34:105, 1985Google Scholar
  151. 151.
    Pead PJ, Saeed AA, Hewitt WG, Brownfield RN: Low immune responses to hepatitis B vaccination among healthy subjects. Lancet 1: 1152, 1985PubMedCrossRefGoogle Scholar
  152. 152.
    Weber DJ, Rutala WA, SamsaGP, SantimawJE, Lemon SM: Obesity as a predictor of poor antibody response to hepatitis B plasma vaccine. JAMA 254: 3187, 1985PubMedCrossRefGoogle Scholar
  153. 153.
    Centers for Disease Control: Recommendations for protection against viral hepatitis. Recommendations of the immunization practices advisory committee. Ann Intern Med 103:391, 1985Google Scholar
  154. 154.
    Craven DE, Awdeh ZL, Kunches LM, Yunis EJ, Dienstag JL, Werner BG, Polk BF, Snydman DR, Platt R, Crumpacker CS, Grady GF, Alper CA: Non responsiveness to hepatitis B vaccine in health care workers. Results of revaccination and genetic typings. Ann Intern Med 105: 356, 1986PubMedGoogle Scholar
  155. 155.
    Szmuness W, Stevens CE, Oleszo WR, Godman A: Passive-active immunisation against hepatitis B: immunogenicity studies in adult Americans. Lancet 1: 575, 1981PubMedCrossRefGoogle Scholar
  156. 156.
    Goudeau A, Coursaget P, Barin F, Dubois F, Chiron JP, Denis F, Diop Mar I: Prevention of hepatitis B by active and passive-active immunization. InViral Hepatitis edited by Szmuness W, Alter HJ, Maynard JE, Philadelphia, Franklin Institute Press, 1981, p 509Google Scholar
  157. 157.
    Couroucé AM, Naret C, Adhémar JP, Cerisier Y, Bouchardeau F, Masselot JP, Delons S, Guesry P: A study of the switch from passive to active immunization in hemodialysis units. In: Hepatitis B Vaccine Symposium, edited by Maupas P, Guesry P, Amsterdam, Elsevier-North Holland, 1981, p 173Google Scholar
  158. 158.
    Mesnier F, Sanchez D, Maurel JP, Moulinier J: Comparative study of active and passive-active immunization in the prevention of hepatitis B infection in high-risk settings. In: Hepatitis B Vaccine Symposium edited by Maupas P, Guesry P, Amsterdam, Elsevier-North Holland, 1981, p 183Google Scholar
  159. 159.
    Coutinho RA, Lelie N, Albrecht-Van Lent P, Reerink-Brongers EE, Stoutjesdijk L, Dees P, Nivard J, Huisman J, Reesink HIV: Efficacy of a heat inactivated hepatitis B vaccine in male homosexuals: outcome of a placebo controlled double blind trial. Br Med J 2: 1305, 1983CrossRefGoogle Scholar
  160. 160.
    Jilg W, Schmidt M, Deinhardt F, Zachoval R: Hepatitis B vaccination: how long does protection last? Lancet 2: 458, 1984PubMedCrossRefGoogle Scholar
  161. 161.
    Grob PJ, Dufek A, Joller-Jemelka HI: Hepatitis B Imfung — wann ist eine Booster Injecktion nötig? (Hepatitis B immunization — when is a booster injection necessary?) Schweiz Med Wschr 115: 394, 1985Google Scholar
  162. 162.
    Hadler SC, Francis DP, Maynard JE, Thompson SE, Judson FN, Echenberg DF, Ostrow DG, O’Malley PM, Penley KA, Altman NL, Braff E, Shipman GF, Coleman PJ, Mandel EJ: Long-term immunogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 315: 209, 1986PubMedCrossRefGoogle Scholar
  163. 163.
    Jungers P, Courouce AM, Laplanche A, Benhamou E: Hepatitis B vaccine. N Engl J Med 316: 47, 1987CrossRefGoogle Scholar
  164. 164.
    Jungers P, Courouce AM, Laplanche A, Benhamou E, Crosnier J: Long-term efficacy and immunogenicity of HE VAC B vaccine in medical staff of hemodialysis units. Proc Eur Symposium on Hepatitis B Immunization, Evaluation and Perspectives, Roma, October 1986.Google Scholar
  165. 165.
    Dienstag JL, Stevens CE, Bhan AK, Szmuness W: Hepatitis B vaccine administered to chronic carriers of hepatitis B surface antigen. Ann Intern Med 96: 575, 1982PubMedGoogle Scholar
  166. 166.
    Dienstag JL, Ryan DM: Occupational exposure to hepatitis B virus in hospital personnel: infection or immunization? Am J Epidemiol 15: 26, 1982Google Scholar
  167. 167.
    Kessler HA, Harris AA, Payne JA, Hudson E, Potkin B, Levin S: Antibodies to hepatitis B surface antigen as the sole hepatitis B marker in hospital personnel. Ann Intern Med 103: 201, 1985Google Scholar
  168. 168.
    Werner BG, Dienstag JL, Kuter BJ, Polk BF, Snydman DR, Craven DE, Crumpacker CS, Platt R, Grady GF: Isolated antibody to hepatitis B surface antigen and response to hepatitis B vaccination. Ann Intern Med 103: 201, 1985PubMedGoogle Scholar
  169. 169.
    Goudeau A, Dubois F: Immune status of anti-HBc positive individuals. Lancet 1: 396, 1984PubMedCrossRefGoogle Scholar
  170. 170.
    Taliani G, Lece R, Furian C, Nuti M, Bernaschi P, De Bac C: Hepatitis vaccination for a wider diagnostic purpose? Lancet 2:173, 1984PubMedCrossRefGoogle Scholar
  171. 171.
    Hadziyannis SJ, Hatzakis A: Response to hepatitis B vaccine of anti-HBc positive subject. In: Hepatitis B Vaccine Symposium (Berne) New Findings and Perspectives, edited by Tron F, Marnes-la Coquette, Pasteur Vaccins, 1984, p 33Google Scholar
  172. 172.
    Kane MA, Hadler SC, Maynard JE: Antibody to hepatitis B surface antigen and screening before hepatitis vaccination. Ann Intern Med 103: 791, 1985PubMedGoogle Scholar
  173. 173.
    Perrillo RP: Screening of health care workers before hepatits B vaccination: more questions than answers. Ann Intern Med 103: 793, 1985PubMedGoogle Scholar
  174. 174.
    Goldblum SE, Reed WP: Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 93: 597, 1980PubMedGoogle Scholar
  175. 175.
    Dobbelstein H: Immune system in uremia. Nephron 17: 409, 1976PubMedCrossRefGoogle Scholar
  176. 176.
    Revillard JP: Immunologic alterations in chronic renal insufficiency. Adv Nephrol 8: 365, 1979Google Scholar
  177. 177.
    Kurz P, Köhler H, Meuer S, Hütteroth T, Meyer zum Büschenfelde KH: Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect. Kidney Int 29:1209, 1986PubMedCrossRefGoogle Scholar
  178. 178.
    Kurz P, Köhler H, Hütteroth T, Weber M, Meyer zum Büschenfelde KH: Immune defect in the early stage of chronic renal failure. Proc Eur Dial Transplant Assoc Eur Ren Assoc 22: 941, 1985Google Scholar
  179. 179.
    Cappel R, Van Beers D, Liesnard C, Dratwa M: Impaired humoral and cell-mediated immune responses in dialyzed patients after influenza vaccination. Nephron 33: 21, 1983PubMedCrossRefGoogle Scholar
  180. 180.
    Linneman CC Jr, First MR, Schiffman G: Response to pneumococcal vaccine in renal transplant and hemodialysis patients. Arch Intern Med 141: 1637, 1981CrossRefGoogle Scholar
  181. 181.
    Linnemann CC Jr, First MR, Schiffman G: Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med 146: 1554, 1986PubMedCrossRefGoogle Scholar
  182. 182.
    Maupas P, Goudeau A, Coursaget P, Drucker J, Bagros P: Hepatitis B vaccine efficacy in high risk settings, a two year study. Intervirology 10: 196, 1978PubMedCrossRefGoogle Scholar
  183. 183.
    Stevens CE, Szmuness W, Goodman AI, Wesely Sa, Fotino M: Hepatitis B vaccine: immune responses in haemodialysis patients. Lancet 2:1211, 1980PubMedCrossRefGoogle Scholar
  184. 184.
    Crosnier J, Jungers P, Courouce AM, Laplanche A, Benhamou E, Degos F, Lacour B, Prunet P, Cerisier Y, Guesry P: Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units. II. Haemodialysis patientsLancet 1: 797, 1981PubMedCrossRefGoogle Scholar
  185. 185.
    Stevens CE, Alter HJ, Taylor PE, Zang EA, Harley EJ, Szmuness W: Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy. N Engl J Med 311:496, 1984PubMedCrossRefGoogle Scholar
  186. 186.
    BommerJ, RitzE, AndrassyK, BommerG, DeinhardtF,Jilg W, Daral G: Effect of vaccination schedule and dialysis on hepatitis B vaccination response in uraemic patients. Proc Eur Dial Transplant Assoc Eur Ren Assoc 20: 161, 1983Google Scholar
  187. 187.
    Bommer J, Grussendorf M, Jilg W, Deinhardt F, Koch HG, Daral G, Bommer G, Rambause M, Ritz E: Vaccination against hepatitis B in patients with renal insufficiency. Proc Eur Dial Transplant Assoc Eur Ren Assoc 21: 300, 1984Google Scholar
  188. 188.
    Köhler H, Arnold W, Renschin G, Dormeyer HH, Meyer zum Büschenfelde KH: Active hepatitis B vaccination of dialysis patients and medical staff. Kidney Int 25: 124, 1984PubMedCrossRefGoogle Scholar
  189. 189.
    De Graff PA, Dankert J, De Zeeuw D, Gips CH, van der Hem GK: Immune response to two different hepatitis B vaccines in haemodialysis patients: a 2-year follow-up. Nephron 40:155, 1985CrossRefGoogle Scholar
  190. 190.
    Carreno V, Mora I, Escuin F, Sanchez-Sicilia L, Alvarez V, Casado S, Alcazar JM, Hernando L, Porres JC, Carrasco JL, Lardinois R: Vaccination against hepatits B in renal dialysis units: short or normal vaccination schedule? Clin Nephrol 24: 215, 1985PubMedGoogle Scholar
  191. 191.
    Lelie PN, Reesink HW, De Jong-Van Manen S, Dees PJ, Reerink-Brongers EE: Immune response to heat-inactivated hepatitis B vaccine in patients undergoing hemodialysis. Enhancement of the response by increasing the dose of hepatitis B surface antigen from 3 to 27 μg. Arch Intern Med 145: 305, 1985PubMedCrossRefGoogle Scholar
  192. 192.
    Benhamou E, Courouce AM, Jungers P, Laplanche A, Degos F, Brangier J, Crosnier J: Hepatitis B vaccine: randomized trial of immunogenicity in hemodialysis patients. Clin Nephrol 21: 143, 1984PubMedGoogle Scholar
  193. 193.
    Courouce AM, Jungers P, Benhamou E, Laplanche A, Crosnier J: Hepatitis B in dialysis patients. N Engl J Med 311:1515, 1984PubMedCrossRefGoogle Scholar
  194. 194.
    Van Geelen JA, Schalm SW, De Visser EM, Heigtink RA: Immune response to hepatitis B vaccine in hemodialysis patients. Nephron 45: 216, 1987PubMedCrossRefGoogle Scholar
  195. 195.
    Michel P, Janin G, El Yafi S, Chevallier P, Girard P, Laville M, Trépo C: Improvement of immune response in dialysis patients to Hevac B vaccine after multiple injections of vaccine. Proc Eur Dial Transplant Assoc Eur Ren Assoc 22:1077, 1985Google Scholar
  196. 196.
    Benhamou E, Couroucé AM, Laplanche A, Jungers P, Tron F, Crosnier J: Long-term results of hepatitis B vaccination in patients on dialysis. N Engl J Med 314: 1710, 1986PubMedGoogle Scholar
  197. 197.
    Rottembourg J, Barthélémy A, Tron F, Laleye B, Boulanger C, Legrain M: Hepatitis B vaccine in uremic patients with end-state renal disease. In: 2nd Hepatitis B Vaccine Symposium (Berne) New Findings and Perspectives, edited by Tron F, Marnes-la-Coquette Pasteur Vaccins, 1984, p 67Google Scholar
  198. 198.
    Jungers P, Chauveau P, Couroucé AM, Mattlinger B, Crosnier J: Hepatitis B vaccine in non-dialysed uraemic patients: preliminary results. Proc Eur Dial Transplant Assoc Eur Ren Assoc 22: 1073, 1985Google Scholar
  199. 199.
    Chauveau P, Loubaris T, Couroucé AM, Mattlinger B, Jüngers P: Immune response to hepatitis B vaccine in non-dialysed uremic patients. In preparationGoogle Scholar
  200. 200.
    Zuckerman AJ: New hepatitis B vaccines. Br Med J 1: 492, 1985CrossRefGoogle Scholar
  201. 201.
    Skelly J, Howard CR, Zuckerman AJ: Hepatitis B polypeptide vaccine preparation in micelle form. Nature 290: 51, 1981PubMedCrossRefGoogle Scholar
  202. 202.
    Neurath AR, Kent SBH, Strick NS, Taylor P, Stevens CE: Hepatitis B virus contains pre-S gene-encoded domians. Nature 315: 154, 1985PubMedCrossRefGoogle Scholar
  203. 203.
    Coursaget P, Barrés JL, Chriron JP, Adamowicz P: Hepatitis B vaccines with and without polymerised albumin receptors. Lancet 1: 152, 1985Google Scholar
  204. 204.
    Milich D, Thornton G, Neurath R, Kent S, Michel ML, Tiollais P, Chisari F: Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen. Science 228: 1195, 1985PubMedCrossRefGoogle Scholar
  205. 205.
    Neurath R, Kent S, Parker K, Prince A, Strick N, Brotman P, Sproul P: Antibodies to a synthetic peptide from pre-S 120–145region of the hepatitis B virus envelope are virus neutralizing. Vaccine 4: 35, 1986PubMedCrossRefGoogle Scholar
  206. 206.
    Mc Aleer WJ, Buynak EB, Maigetter RZ, Wampler DE, Miller WJ, Hilleman MR: Human hepatitis B vaccine from recombinant yeast. Nature 307: 178, 1984CrossRefGoogle Scholar
  207. 207.
    Jilg W, Lobeer B, Schmidt M, Wilkse B, Zoulek G, Deinhardt F: Clinical evaluation of a recombinant hepatitis B vaccine. Lancet 2: 1174, 1985Google Scholar
  208. 208.
    Scolnick EM, Mc Lean AA, West DJ, Mc Aller WJ, Miller WJ, Buynack EB: Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA. JAMA 251:2812, 1984PubMedCrossRefGoogle Scholar
  209. 209.
    Brown SE, Stanley C, Howard CR,Zuckerman AJ, Steward MW: Antibody responses to recombinant and plasma derived hepatitis B vaccines. Br Med J I: 159, 1986Google Scholar
  210. 210.
    Hollinger FB, Troisi CI, Pepe PE: Anti-HBs responses to vaccination with a human hepatitis B vaccine made by recombinant DNA technology in yeast. J Infect Dis 153: 156, 1986PubMedCrossRefGoogle Scholar
  211. 211.
    Grady GF: The here and now of hepatitis B immunization. N Engl J Med 315:250, 1986PubMedCrossRefGoogle Scholar
  212. 212.
    Stevens CE, Taylor PE, Rubinstein P, Ting RCY, Badner AJ, Sarngadharan MG, Gallo RG: Safety of the hepatitis B vaccine. N Engl J Med 312: 375, 1985PubMedCrossRefGoogle Scholar
  213. 213.
    Jacobson IM, Dienstag JL, Zachoval R, Hanrahan BA, Watkins E, Rubin RH: Lack of effect of hepatitis B vaccine on T-cell phenotypes. N Engl J Med 311: 1030, 1984PubMedCrossRefGoogle Scholar
  214. 214.
    Alter MJ, Favero MS, Maynard JE: Hepatitis B vaccine use in chronic hemodialysis centers in the United States. JAMA 254:3200, 1985PubMedCrossRefGoogle Scholar
  215. 215.
    Finch RG: Time for action on hepatitis immunisation. Br Med J 294:197, 1987CrossRefGoogle Scholar
  216. 216.
    Polakoff S: Acute viral hepatitis B: Laboratory reports 1980–84. Br Med J 293: 37, 1986CrossRefGoogle Scholar
  217. 217.
    Mulley AG, Silverstein MD, Dienstag JL: Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med 307: 644, 1982PubMedCrossRefGoogle Scholar
  218. 218.
    Strickler AC: Hepatitis B vaccine. N Engl J Med 316: 47, 1987CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • Jean Crosnier
  • FranÇoise Degos
  • Paul Jungers

There are no affiliations available

Personalised recommendations